Persistent Atrial Fibrillation (AF) (Asia Pacific) Observational Study

  • STATUS
    Recruiting
  • participants needed
    100
  • sponsor
    Abbott Medical Devices
Send
Updated on 19 February 2024
See if I qualify
atrial fibrillation
persistent atrial fibrillation
catheter ablation
fibrillation
antiarrhythmic drug
cardiac ablation

Summary

The objective of this clinical trial is to collect safety and effectiveness data for the TactiCath Contact Force Ablation Catheter, Sensor Enabled (TactiCath SE) in the APAC patient population for the treatment of drug refractory, symptomatic persistent atrial fibrillation when following standard electrophysiology mapping and radiofrequency (RF) ablation procedures.

Description

The PerAF APAC trial is a prospective, single arm, non-randomized, observational, post-market clinical investigation. Approximately 100 subjects will be enrolled at up to 15 sites in South Korea, Singapore, Hong Kong, Taiwan, and India. Centers in other countries within APAC may be approached for participation in the clinical investigation as needed. Subjects will be followed for 15-months after their initial ablation procedure. The primary effectiveness and safety endpoints will be evaluated through 15-months. A core lab will independently assess AF/AFL/AT recurrence via Holter monitoring at the 6-month and 15-month follow-up visits. All serious adverse events (SAEs) will be independently adjudicated by qualified physicians not participating in the trial

Details
Condition Arrhythmia, Arrhythmia, Atrial Fibrillation, Atrial Fibrillation
Age 18years - 100years
Treatment TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE)
Clinical Study IdentifierNCT04244396
SponsorAbbott Medical Devices
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

b'Signed informed consent'
b'Documented symptomatic persistent AF, defined as continuous AF sustained >7-days but'
b'<1 year documented by:'
b"Physician's note AND one of the following:"
b'24-hr Holter showing continuous AF within 90-days of the procedure OR'
b'2 ECGs (from any form of rhythm monitoring) showing continuous AF, taken at least'
b'7-days apart'
b'Refractory or intolerant to at least one Class I or III antiarrhythmic drug (AAD) as'
b'evidenced by recurrent symptomatic AF NOTE: Intolerant = unable, unwilling, or refusal'
b'to take AADs'
b'\\u226518 years of age'
b'Able and willing to complete all pre-, post-, and follow-up testing and requirements'

Exclusion Criteria

b'Continuous AF >12 months.'
b'Previous left atrial (LA) surgical or catheter ablation for AF'
b'Any cardiac procedure within 90-days prior to procedure (Diagnostic procedures with no'
b'intervention are not considered a surgical or percutaneous surgical procedure)'
b'Coronary artery bypass graft (CABG) surgery within 6-months prior to procedure'
b'Valvular cardiac surgical/percutaneous procedure'
b'Any carotid stenting or endarterectomy'
b'Documented LA thrombus on imaging'
b'LA diameter >50 mm'
b'Left Ventricular Ejection Fraction (LVEF) <40%'
b'Unable to take anticoagulation medication'
b'History of blood clotting or bleeding abnormalities'
b'Myocardial Infarction (MI), acute coronary syndrome, Percutaneous coronary'
b'intervention (PCI) within the 3-mos prior to the procedure'
b'Documented thromboembolic event within 12-months prior to the procedure'
b'Rheumatic heart disease'
b'Uncontrolled heart failure or New York Heart Association (NYHA) Class III or IV'
b'Severe mitral regurgitation'
b'Cardiac transplantation or other cardiac surgery within 12-months of the ablation'
b'procedure'
b'Unstable angina at the time of the procedure'
b'Acute illness or active systemic infection'
b'AF secondary to non-cardiac or reversible causes'
b'Diagnosed atrial myxoma'
b'Presence of intracardiac defibrillator (ICD) or cardiac resynchronization therapy'
b'defibrillator (CRT-D)'
b'Significant pulmonary disease that produces chronic symptoms'
b'Significant congenital anomaly or other anatomic or comorbid condition that may impact'
b'cientific soundness of study'
b'Pregnant or nursing subjects'
b'Enrollment in another study that may interfere with this study'
b'Presence of a condition preventing appropriate vascular access'
b'Life expectancy <12-months'
b'BMI >40 kg/m2'
b'Known sensitivity to contrast media'
b'Renal failure requiring dialysis'
b'Presence of other medical, social, or psychological condition that in the'
b"investigator's opinion, limits the subject's ability to participate in the study or"
b'impact the scientific soundness of the study'
b'History of atriotomy or ventriotomy'
b'Implanted left atrial appendage occlusion device'
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

atrial fibrillation
persistent atrial fibrillation
catheter ablation
fibrillation
antiarrhythmic drug
cardiac ablation

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.